Masitinib in the Treatment of Patients With Primary Progressive or Non-active Secondary Progressive Multiple Sclerosis

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

800

Participants

Timeline

Start Date

June 28, 2022

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions
Progressive Multiple Sclerosis
Interventions
DRUG

Placebo

treatment per os

DRUG

Masitinib (4.5)

Masitinib (titration to 4.5 mg/kg/day)

Trial Locations (37)

Unknown

Service de Neurologie Hôpital Henri-Mondor, Créteil

Hôpital Roger Salengro, Lille

Hôpital Pasteur - CHU de Nice, Nice

Centre Hospitalier Universitaire Nimes - Service de Neurologie, Nîmes

Centre hospitalier intercommunal de Poissy-Saint-Germain-en-Laye, Poissy

Le Centre hospitalier universitaire de Poitiers, Poitiers

Centre Hospitalier Universitaire de Rouen, Rouen

Centre Hospitalier Universitaire de Strasbourg, Strasbourg

Centre Hospitalier Universitaire Toulouse, Toulouse

Athens Naval Hospital, Athens

Eginition Hospital, Athens University Medical School, Athens

General University Hospital of Larissa, Larissa

AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki

Private Clinic ELPIS, Volos

"Azienda Ospedaliero Universitaria Policlinico G.Rodolico -San Marco", Catania

Nzoz Neuro-Medic, Katowice

NOVI-MED, Ksawerów

Centrum Neurologii Krzysztof Selmaj, Lodz

NZOZ Neuro-Med, Lublin

Generała Jarosława Dąbrowskiego, Oświęcim

NZOZ Neuro-Kard, Poznan

Clinical Best Solutions, Warsaw

State Budgetary Institution of Health of the City of Moscow City Polyclinic #2, Moscow

Perm Regional Clinical Hospital, Perm

City Hospital No. 40 Kurortny District, Saint Petersburg

"LLC Center of socially significant diseases", Saint Petersburg

Hospital del Mar, Barcelona

Hospital Universitario de Cruces, Bilbao

Gregorio Marañón General University Hospital, Madrid

Hospital Clínico San Carlos, Madrid

Hospital Universitario y Politécnico La Fe, Valencia

Sahlgrenska University Hospital, Gothenburg

Centrum för neurologi, Stockholm

Lviv Regional Clinical Hospital, Lviv

Rivne Regional Specialized Dispensary for Radiation Protection of the Population Municipal Enterprise, Rivne

"Communal Non-Profit Enterprise Ternopil Regional Clinical Psychoneurological Hospital of Ternopil Regional Council, Department of Neurology #1", Ternopil

Salutem Medical Center, Vinnytsia

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AB Science

INDUSTRY